Tracheobronchomalacia (TBM)
Tracheobronchomalacia, known as TBM, is a degenerative disease that causes the complete, or near-complete, collapse of the airway due to the breakdown of cartilage in the trachea.
Often masquerading as chronic cough and/or shortness of breath, even after prescribed medications, it progressively worsens, often along with bouts of pneumonia and other respiratory infections. This leads to a significantly reduced quality of life, and even death, if left untreated.
Affecting Millions
TBM is a vastly underdiagnosed disease, currently requiring an expensive, inconvenient dynamic CT to diagnose, and thus has been virtually untreated for decades.
Although there is a current lack of awareness of TBM, the prevalence has been estimated to be as high as 10% in the general population– with approximately half of the nation’s 16 million COPD patients also likely suffering from TBM.
Previous Treatment Worse Than Disease
Until now, the only option for people suffering from TBM has been extremely risky and invasive open surgery. Many patients are simply not healthy enough to go through with the procedure due to the significant risk of complications or death.
The Solution: LM Scaffold System™
Lazzaro Medical has developed the world’s first minimally invasive robotic TBM repair surgery using the LM Scaffold System™. This system restores healthy breathing for previously untreatable people—dramatically reducing operating times by an estimated 50% and shortening patient recovery times from months to days.
Extending the Platform
In addition to the LM Scaffold System™ robotic repair of TBM, our platform includes comprehensive training programs for hospitals and a product development pipeline including the LM DL Tube™ and LM Scope™.
Diagnostic tool that can be used by otolaryngologists and pulmonologists “in office” drastically shortening time/effort to correctly and quickly diagnose TBM
Comprehensive training program for thoracic surgeons to use the Minimally Invasive Tracheal Repair (MITR™) and hospitals to take advantage of this lucrative surgery while saving lives
More efficient patent-pending non-occlusive double lumen endotracheal tube that will further simplify our MITR™ procedure and other surgeries